Publication:
Mortality Associated with Bacteremia Due to Colistin-Resistant Klebsiella pneumoniae with High-Level Meropenem Resistance: Importance of Combination Therapy without Colistin and Carbapenems.

Research Projects
Organizational Units
Journal Issue
Abstract
Combination therapy including colistin and a carbapenem has been found to be associated with lower mortality in the treatment of bloodstream infections (BSI) due to KPC-producing Klebsiella pneumoniae when the isolates show a meropenem or imipenem MIC of
Description
DeCS Terms
CIE Terms
Keywords
Klebsiella pneumoniae, bacteremia, carbapenems, colistin, mortality
Citation